Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,774 total articles

22nd Century Group Reports First Quarter 2026 Financial Results

22nd Century Group Reports First Quarter 2026 Financial Results

22nd Century Group continues to expand its commercial footprint for its proprietary low nicotine VLN® tobacco products, targeting over 5,000 retail outlets by the end of 2026. The company reported a slight increase in net revenues to $4.1 million in Q1 2026, though it remains operating at a loss, with a focus on regulatory engagement and portfolio …

KBR’s Mission Technology Solutions Awarded Two Task Orders Supporting US Air Force Operations in Southwest Asia

KBR’s Mission Technology Solutions Awarded Two Task Orders Supporting US Air Force Operations in Southwest Asia

KBR's Mission Technology Solutions division has been awarded two firm-fixed-price task orders under the Air Force Contract Augmentation Program (AFCAP) V to provide transient aircraft services and dining facility services at key U.S. Air Force locations in Southwest Asia, with a combined ceiling value exceeding $41 million. The contracts strengthen…

Himax Technologies, Inc. Declares Cash Dividend for FY2025

Himax Technologies, Inc. Declares Cash Dividend for FY2025

Himax Technologies, a Nasdaq-listed fabless semiconductor company specializing in display drivers and imaging products, declared a cash dividend of $0.252 per ADS for FY2025. This dividend represents a 100% payout ratio of last year's profits, highlighting the company's healthy balance sheet and positive cash flow projections. Himax plans to suppor…

Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial

Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial

Oculis Holding AG announced it has received a Special Protocol Assessment (SPA) from the U.S. FDA for its Phase 3 PIONEER-1 trial evaluating Privosegtor for optic neuritis treatment. The SPA confirms FDA agreement on the trial's design and endpoints supportive of NDA submission, pending successful results. Privosegtor, a novel neuroprotective candi…

TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry

TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry

TOMI Environmental Solutions, a U.S. Nasdaq-listed company specializing in disinfection technology, clarified its $120 million all-stock letter of intent to merge with Carbonium Core, a U.S.-based developer of nuclear-grade graphite for advanced nuclear reactors. This acquisition positions TOMI in the multi-billion-dollar graphite market, supportin…

Apollo Funds Complete Acquisition of Prosol Group

Apollo Funds Complete Acquisition of Prosol Group

Apollo-managed funds have completed the acquisition of a majority stake in Prosol Group, a leading French multi-specialist in fresh food businesses and food retail. Prosol operates nearly 450 stores under brands like Grand Frais and fresh., with a strong vertically integrated supply chain. The acquisition aims to fuel Prosol's long-term growth ambi…

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

Catalyst Pharmaceuticals announces a settlement with Hetero Labs Ltd. to resolve patent litigation concerning FIRDAPSE (amifampridine). Under the agreement, Hetero will receive a license to market generic FIRDAPSE starting January 2035, pending FDA approval. The settlement ends all pending patent disputes related to FIRDAPSE and aligns with earlier…

Shell plc First Quarter 2026 Interim Dividend

Shell plc First Quarter 2026 Interim Dividend

Shell plc announced an interim dividend of $0.3906 per ordinary share for Q1 2026, with details on currency options for dividend payments and dividend reinvestment programs. Key dates for dividend eligibility and payment were provided, alongside cautionary forward-looking statements reflecting the company's operational and financial outlook amid ma…

Shell Plc 1st Quarter 2026 Unaudited Results

Shell Plc 1st Quarter 2026 Unaudited Results

Shell plc announced its unaudited financial results for the first quarter of 2026, showing increased income attributable to shareholders and adjusted earnings driven by stronger downstream and renewables performance, despite lower oil and gas volumes influenced by geopolitical disruption. The company entered a definitive agreement to acquire ARC Re…

CMB.TECH announces Q1 2026 results on 19/05/2026

CMB.TECH announces Q1 2026 results on 19/05/2026

CMB.TECH NV, a leading diversified maritime group listed on NYSE and European exchanges, announces the release of its first quarter 2026 earnings on May 19, 2026, prior to market open. The company will host a webcast conference call to discuss these results, providing investors an opportunity to gain insights into the company's financial and operat…

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders

Pharming Group announced multiple presentations at the 2026 Clinical Immunology Society Annual Meeting, focusing on interim data from long-term studies of leniolisib in pediatric patients with APDS and clinical experience in CVID and related disorders. The data support ongoing Phase II trials evaluating leniolisib’s safety and efficacy in treating …

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026

Pharming Group reported Q1 2026 revenues of $72.4M, driven by a 34% increase in Joenja® sales and continued RUCONEST® revenues amid strategic market exits. The company secured pediatric approval for Joenja® in Japan, received a positive CHMP opinion in Europe, and resubmitted its pediatric sNDA in the U.S., positioning for label expansion. Pharming…

Suja Life Announces Pricing of Initial Public Offering

Suja Life Announces Pricing of Initial Public Offering

Suja Life, Inc., a producer of organic and functional beverages, has priced its initial public offering (IPO) of 8,888,889 shares at $21.00 per share, with plans to list on Nasdaq under the ticker SUJA. The company expects to raise about $173.6 million net proceeds, which will be used primarily to repay debt, reward employees, and cover offering ex…

McEwen Generates Strong Q1 Results & Advances Multi-Asset Growth Strategy; Net Income $33.4M ($0.56 per Share) vs. Net Loss $6.3M ($0.12 per Share) in Q1 2025; Internally Funding Key Projects to Double Production by 2030

McEwen Generates Strong Q1 Results & Advances Multi-Asset Growth Strategy; Net Income $33.4M ($0.56 per Share) vs. Net Loss $6.3M ($0.12 per Share) in Q1 2025; Internally Funding Key Projects to Double Production by 2030

McEwen Inc. announced robust Q1 2026 results with net income of $33.4 million, reversing a prior net loss, driven by higher gold prices and increased production. The company is advancing multiple mining projects across Canada, the USA, Mexico, and Argentina, targeting to increase gold equivalent ounces production from approximately 114,000-126,000 …

Fortuna Reports Results for the First Quarter 2026

Fortuna Reports Results for the First Quarter 2026

Fortuna Mining Corp. announced strong financial and operational results for Q1 2026, including record free cash flow of $174 million and adjusted net income of $111 million. The company produced 72,872 gold equivalent ounces, maintaining on-track guidance for 2026. Mineral reserves expanded by 15% year-over-year, supporting growth prospects with po…

Enerflex Ltd. Announces Election of Directors

Enerflex Ltd. Announces Election of Directors

Enerflex Ltd., a global provider of modular natural gas, power technology, and treated water solutions, reported that all 10 of its nominated directors were elected by shareholders at the Annual and Special Meeting held virtually on May 6, 2026. The voting results showed strong shareholder approval across all nominees. The company emphasized its co…

Ryman Hospitality Properties, Inc. Declares Second Quarter Dividend

Ryman Hospitality Properties, Inc. Declares Second Quarter Dividend

Ryman Hospitality Properties, Inc., a leading hospitality REIT specializing in upscale convention center resorts and entertainment, announced a second quarter cash dividend of $1.20 per share payable on July 15, 2026. The company operates a portfolio of major convention center hotels and entertainment venues primarily in the U.S., managed by Marrio…